Delcath elects Dr Jennifer Simpson as president & CEO.
M2 EQUITYBITES-May 27, 2015-Delcath elects Dr Jennifer Simpson as president & CEO
(C)2015 M2 COMMUNICATIONS http://www.m2.com
The board of directors of Delcath Systems (NasdaqCM:DCTH), a medical device company, revealed on Tuesday that it has appointed Jennifer Simpson, PhD, MSN, CRNP as its president and chief executive officer with immediate effect.
In 2012, Dr Simpson joined Delcath as executive vice president of Global Marketing, served as interim president and chief executive officer of Delcath since September 2014 as well as its interim co-president and co-chief executive officer from September 2013 to September 2014.
Dr Simpson recently served as vice president, Global Marketing, Oncology Brand Lead at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company.
Previously, Dr Simpson has worked as vice president, Product Champion, associate vice president, Product Champion at ImClone, product director, Oncology Therapeutics Marketing at Ortho Biotech as well as spent a decade as a hematology/oncology nurse practitioner and educator at the start of her career.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||May 27, 2015|
|Previous Article:||The Rite Aid Foundation awards USD1.3m to Folds of Honor in an aid to education.|
|Next Article:||Intellipharmaceutics International's Rexista Oxycodone XR extended-release tablets development programme awarded US FDA's fast track designation.|